Cargando…
Advances in the discovery of cathepsin K inhibitors on bone resorption
Cathepsin K (Cat K), highly expressed in osteoclasts, is a cysteine protease member of the cathepsin lysosomal protease family and has been of increasing interest as a target of medicinal chemistry efforts for its role in bone matrix degradation. Inhibition of the Cat K enzyme reduces bone resorptio...
Autores principales: | Lu, Jun, Wang, Maolin, Wang, Ziyue, Fu, Zhongqi, Lu, Aiping, Zhang, Ge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010086/ https://www.ncbi.nlm.nih.gov/pubmed/29723068 http://dx.doi.org/10.1080/14756366.2018.1465417 |
Ejemplares similares
-
Cathepsin K: The Action in and Beyond Bone
por: Dai, Rongchen, et al.
Publicado: (2020) -
Azanitrile Cathepsin K Inhibitors: Effects on Cell Toxicity, Osteoblast-Induced Mineralization and Osteoclast-Mediated Bone Resorption
por: Ren, Zhong-Yuan, et al.
Publicado: (2015) -
Advances in the discovery of exosome inhibitors in cancer
por: Zhang, Huarui, et al.
Publicado: (2020) -
Actin-binding protein coronin 1A controls osteoclastic bone resorption by regulating lysosomal secretion of cathepsin K
por: Ohmae, Saori, et al.
Publicado: (2017) -
Morning vs evening dosing of the cathepsin K inhibitor ONO-5334: effects on bone resorption in postmenopausal women in a randomized, phase 1 trial
por: Eastell, R., et al.
Publicado: (2015)